Oncology

Filter

Optimising Patient Outcomes in Advanced Gastrointestinal Stromal Tumours (GIST) in Europe

February 2025

The European Society for Medical Oncology (ESMO) guidelines recommend life-long systemic tyrosine kinase inhibitor (TKI) therapies for…

Optimising Patient Outcomes in Advanced Gastrointestinal Stromal Tumours (GIST) in Europe

The European Society for Medical Oncology (ESMO) guidelines recommend life-long systemic tyrosine kinase inhibitor (TKI) therapies for…

Benefit of Dual Immunotherapy in GI Cancers

This infographic summarises three ongoing studies that demonstrate the benefit of dual immunotherapy combination therapy compared…

Anti-Mitotic Activity and Downstream Immune Response of TTFields Therapy

Discover how TTFields therapy works. This infographic illustrates how TTFields therapy effectively targets and disrupts cancer cell…

Elacestrant Monotherapy as a Second-Line Treatment for ER-Positive, HER2-Negative Advanced Breast Cancer with ESR1 Mutations

This infographic presents data from the EMERALD trial of elacestrant versus standard-of-care therapy in these patients, demonstrating that…

ESR1-Mutation Testing at First Progression in ER-Positive, HER2-Negative Advanced Breast Cancer

This infographic, the second in a three-part series, explores the prevalence of ESR1 mutations in patients with ER+/HER2- advanced breast…

Unmet Needs in ER+/HER2- Advanced Breast Cancer Therapy

This infographic, the first in a three-part series, explores the development of resistance to endocrine therapy in ER-Positive, HER2-Negative advanced…

Unravelling HER2+ Breast Cancer

A highly engaging infographic providing information on the incidence, diagnosis and treatment options for HER2+ breast cancer. It touches…

Cancer Vaccines

An insightful infographic summarising the latest in cancer vaccines research. Information provided summarises the prevalence of certain…

Loading posts...